Crestline Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-21,830
Closed -$1.61M 270
2018
Q1
$1.61M Buy
+21,830
New +$1.63M 0.2% 98
2017
Q3
Sell
-24,056
Closed -$1.38M 164
2017
Q2
$1.38M Buy
24,056
+4,629
+24% +$272K 0.19% 64
2017
Q1
$1.18M Buy
19,427
+3,230
+20% +$183K 0.22% 47
2016
Q4
$889K Buy
+16,197
New +$777K 0.22% 28

Other funds holding NGVT

Crestline Management's NGVT Position: Q2 2018 in Review

Crestline Management sold out of Ingevity (NGVT) in Q2 2018, closing a stake of 21,830 shares — an estimated $1.61M sold.

Crestline Management first reported a position in NGVT in Q4 2016 and held it in 4 quarters. The position peaked at $1.61M in Q1 2018. 309 funds tracked by Wall St. Rank hold NGVT as of Q2 2018.

  • Crestline Management reported no remaining Ingevity position as of Q2 2018 after selling out during the quarter.
  • Crestline Management sold 21,830 Ingevity shares in Q2 2018, an estimated $1.61M.
  • Crestline Management first reported a position in Ingevity in Q4 2016 and held it in 4 quarters.
  • Crestline Management's Ingevity position peaked at $1.61M in Q1 2018.
  • 309 funds tracked by Wall St. Rank held Ingevity as of Q2 2018.

Based on Crestline Management's 13F filing for Q2 2018, filed 14 Aug 2018.